Papers by Nigel Mackman
Page 1 · newest first
- Lack of canonical PAR4 activation is associated with reduced arterial and venous thrombosis in mice2026
- In a nutshell: Explaining joint and muscle bleeding in individuals with haemophilia A and BBritish Journal of Haematology · 2026
- Carbon tetrachloride (CCl4)-induced liver injury activates hepatocyte-independent tissue factor-driven coagulationJournal of Thrombosis and Haemostasis · 2026
- Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced MyocarditisJournal of the American College of Cardiology · 2013
- Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemiaResearch and Practice in Thrombosis and Haemostasis · 2025
- Potential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever VirusesArteriosclerosis Thrombosis and Vascular Biology · 2025
- Association between clonal mutations in Acute Myeloid Leukemia and novel fibrinolytic biomarkersBlood · 2025
- Profibrinolytic Factors and Cancer Progression, Metastasis, and SurvivalArteriosclerosis Thrombosis and Vascular Biology · 2025
- Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysisNature Communications · 2025
- Evaluation of a new commercial assay for the measurement of tissue factor activity of extracellular vesicles isolated from human plasmaResearch and Practice in Thrombosis and Haemostasis · 2025
- Optimization of a Western blot protocol for the detection of low levels of tissue factor in human cellsResearch and Practice in Thrombosis and Haemostasis · 2025
- Anticoagulant therapy and altered tissue factor expression protect against experimental placental and cerebral malariaPLoS Pathogens · 2025
- Prothrombotic Biomarkers Are Not Altered by Wood Smoke: A Pilot Controlled Exposure StudySHILAP Revista de lepidopterología · 2025
- The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgeryBlood Advances · 2025
- Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis—Brief ReportArteriosclerosis Thrombosis and Vascular Biology · 2025
- Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infectionNature Communications · 2025
- Extravascular coagulation regulates haemostasis independently of activated platelet surfaces in an in vivo mouse modelCommunications Biology · 2025
- TGF-β Receptor–dependent Tissue Factor Release and Proteomic Profiling of Extracellular Vesicles from Mechanically Compressed Human Bronchial Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology · 2025
- Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertensionJHLT Open · 2024
- Platelets are Protective in Early Abdominal Aortic Aneurysm Formation2024
- Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE-/-vs. Ldlr-/-Mice2024
- Challenges with measuring tissue factor antigen and activity in human plasmaBlood Vessels Thrombosis & Hemostasis · 2024
- Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer SymptomsInflammation · 2024
- Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic targetBlood · 2024
- 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis modelBlood · 2024
- Abstract 155: Plasma Kallikrein Is A Key Driver Of Basal Activation Of Coagulation Under Conditions Of C1 Inhibitor DeficiencyArteriosclerosis Thrombosis and Vascular Biology · 2024
- Plasma kallikrein supports FXII-independent thrombin generation in mouse whole bloodBlood Advances · 2024
- Commentary: Macrophage IL-1β-positive microvesicles exhibit thrombo-inflammatory properties and are detectable in patients with active juvenile idiopathic arthritisFrontiers in Immunology · 2024
- Tissue Factor and COVID-19 Associated ThrombosisArteriosclerosis Thrombosis and Vascular Biology · 2024
- Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexesProceedings of the National Academy of Sciences · 2024
- Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection2024
- Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factorResearch and Practice in Thrombosis and Haemostasis · 2024
- Commentary: Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosisFrontiers in Immunology · 2023
- Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia2023
- Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisBlood · 2023
- Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerHaematologica · 2023
- 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse model of hemostasis2023
- Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolismJournal of Thrombosis and Haemostasis · 2023
- Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemiaBlood Advances · 2023
- Glycoprotein VI is Critical for the Detection and Progression of Abdominal Aortic Aneurysms2023
- Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of CoagulationThrombosis and Haemostasis · 2023
- Detection of tissue factor–positive extracellular vesicles using the ExoView R100 systemResearch and Practice in Thrombosis and Haemostasis · 2023
- Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary reviewNeuro-Oncology · 2023
- High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolismJournal of Thrombosis and Haemostasis · 2023
- Data from Tissue Factor–Activated Coagulation Cascade in the Tumor Microenvironment Is Critical for Tumor Progression and an Effective Target for Therapy2023
- Mechanisms of cancer-associated thrombosisResearch and Practice in Thrombosis and Haemostasis · 2023
- Tissue factor activity of small and large extracellular vesicles in different diseasesResearch and Practice in Thrombosis and Haemostasis · 2023
- Evaluation of four commercial ELISAs to measure tissue factor in human plasmaResearch and Practice in Thrombosis and Haemostasis · 2023
- Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic CancerThrombosis and Haemostasis · 2023
- C1 inhibitor deficiency enhances contact pathway mediated activation of coagulation and venous thrombosisBlood · 2023